Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Impact of Siderophore Genes on Cefiderocol Susceptibility in Carbapenem Resistant Hypervirulent Klebsiella Pneumoniae

View source ↗

Summary

An update on a clinical trial examining whether siderophore gene profiles affect cefiderocol susceptibility in carbapenem-resistant hypervirulent Klebsiella pne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefiderocol (cefiderocol)

Snippet

Sponsor: Sohag University | Conditions: Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae Infection | Status: NOT_YET_RECRUITING